Meeting
2017 ASCO Annual Meeting
Which patient characteristics drive treatment decisions in elderly patients with early stage hormone receptor–positive breast cancer?
Authors
Sacha Satram-Hoang
Q.D. Research, Inc., Granite Bay, CA
Sacha Satram-Hoang , Carolina M. Reyes , Alisha Stein , Khang Q. Hoang , Faiyaz Momin , Patricia Cortazar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 35, 2017 (suppl; abstr 538)
DOI
10.1200/JCO.2017.35.15_suppl.538
Abstract #
538
Poster Bd #
138
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Feasibility of implementing an intervention to reduce burden of adjuvant therapy for older women with low-risk breast cancer.
First Author: Jean L. Wright
Poster
2023 ASCO Annual Meeting
Long-term oncologic outcomes after omitting axillary surgery in older women with early stage, node-negative breast cancer: A systematic review and meta-analysis.
First Author: Mariam Rana
Poster
2022 ASCO Annual Meeting
Comparison of predicted benefit using RS clin versus observed benefit in a U.S. registry of stage I ER-positive HER2-negative high oncotype DX RS breast cancer.
First Author: Christopher David Walden
Poster
2022 ASCO Annual Meeting
Adherence to EndoPredict test scores for extended endocrine therapy management in the prospective EndoPredict Extended Endocrine Trial (EXET).
First Author: Adam Brufsky